There are 3164 resources available
CN47 - Consensus research priorities for cancer nursing in Europe: A Delphi study
Presenter: Amanda Drury
Session: MASCC-EONS collaborative session: Nursing researchers’ role in supportive care implementation
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: MASCC-EONS collaborative session: Nursing researchers’ role in supportive care implementation
Resources:
Webcast
1535O - Cost and value of EMA-registered checkpoint inhibitors for solid tumours in the Netherlands
Presenter: Atse Huisman
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
LBA4 - Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase III KEYNOTE-522 study
Presenter: Peter Schmid
Session: Presidential Symposium II: Practice-changing trials
Resources:
Abstract
Slides
Webcast
Should IO be considered the new standard of care in advanced EC?
Presenter: Ana Oaknin
Session: What we know and what we should know on immunotherapy and endometrial cancer (EC)
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Aisha Miah
Session: Definition and clinical implication of response in localised sarcomas
Resources:
Slides
Webcast
Introduction
Presenter: Emiliano Calvo
Session: Current advances in clinical pharmacology within oncology, and its relevance for daily practice
Resources:
Slides
Webcast
1536O - Indication-specific pricing and weighted-average pricing: Estimated price and cost savings for cancer drugs
Presenter: Daniel Michaeli
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Webcast
Implementation in clinical practice of therapeutic drug monitoring (TDM) of kinase inhibitors anno 2024
Presenter: Ron Mathijssen
Session: Current advances in clinical pharmacology within oncology, and its relevance for daily practice
Resources:
Slides
Webcast
Digging into the biology: Who are the responders?
Presenter: Xavier Matias-Guiu
Session: What we know and what we should know on immunotherapy and endometrial cancer (EC)
Resources:
Slides
Webcast